Cell Therapeutics Inc. (CTIC) Reports In-Line Q4 Loss of $0.20/Sh

February 28, 2013 5:35 PM EST Send to a Friend

Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.20), in-line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Cell Therapeutics Inc. (CTIC) Reports In-Line Q4 Loss of $0.20/Sh

Member Login

Free News Feed